Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
APOLLO ENDOSURGR RG (NQ: APEN)
6.500 USD  -0.110 (-1.66%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 71,783
Open 6.630
Bid (Size) 3.200 (100)
Ask (Size) 6.840 (200)
Prev. Close 6.610
Today's Range 6.310 - 6.630
52wk Range 3.550 - 8.500
Shares Outstanding 17,509,449
Dividend Yield N/A
Performance
YTD
+10.36%
+10.36%
1 Month
-3.85%
-3.85%
3 Month
-3.85%
-3.85%
6 Month
+23.34%
+23.34%
1 Year
-14.59%
-14.59%
Top News
More News
Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter’s Full Exercise of Over-Allotment Option
Apollo Endosurgery, Inc. (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the closing of its previously announced underwritten... Read More
from Business Wire News Releases
Apollo Endosurgery, Inc. Announces Pricing of $20.6 Million Public Offering of Common Stock
Apollo Endosurgery, Inc. Announces Pricing of $20.6 Million Public Offering of Common Stock Read More
from Business Wire News Releases
More News
Read More
Apollo Endosurgery, Inc. Announces Commencement of Public Offering of Common Stock
from Business Wire News Releases
Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW)
from Business Wire News Releases
Detailed Research: Economic Perspectives on McGrath RentCorp, Universal Forest Products, Venator Materials, Armada Hoffler Properties, Atlantic Coast Financial, and Apollo Endosurgery — What Drives Gr
from GlobeNewswire News Releases
Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery
from Business Wire News Releases
Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA® Intragastric Balloon System
from Business Wire News Releases
Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week® 2018 titled: “Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon”
from Business Wire News Releases
Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors
from Business Wire News Releases
Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference
from Business Wire News Releases
Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.